The license provides Enigma with access to claims of US patent that describe methods for monitoring nucleic acid amplification in real-time. This is the first such license Applied Biosystems has granted to the method claims of the patent.
This is said to complement Enigma’s existing license under certain patents owned by Applied Biosystems for real-time polymerase chain reaction thermal cyclers.